Year: 2020
Type: article
Source: Neuron
Authors: Na Zhao, Yingxue Ren, Yu Yamazaki, Wenhui Qiao, Fuyao Li, Lindsey M. Felton, Siamak Mahmoudiandehkordi, Alexandra Kueider-Paisley, Berkiye Sonoustoun, Matthias Arnold, Francis Shue, Jiaying Zheng, Olivia N. Attrebi, Yuka A. Martens, Zonghua Li, Ligia Bastea, Axel D. Meneses, Kai Chen, J. Will Thompson, Lisa St John-Williams, Masaya Tachibana, Tomonori Aikawa, Hiroshi Oue, Lucy Job, Akari Yamazaki, Chia-Chen Liu, Peter Storz, Yan W. Asmann, Nilüfer Ertekin-Taner, Takahisa Kanekiyo, Rima Kaddurah-Daouk, Guojun Bu
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: bronze
Funders: Michael J. Fox Foundation for Parkinson's Research, Mayo Clinic, Club Foundation, BrightFocus Foundation, Mayo Foundation for Medical Education and Research, Arizona Department of Health Services, Arizona Biomedical Research Commission, National Institutes of Health, Japan Society for the Promotion of Science, National Institute on Aging, National Cancer Institute, National Institute of Neurological Disorders and Stroke
Awards: G1045600774, Epidemiologic Study of Neural Reserve and Neurobiology of Aging, G1154988614, Molecular pathobiology of soluble TREM2 in Alzheimer's disease, G1951116564, TREM2-mediated microglial dynamic function in Alzheimer disease, Integrative translational discovery of vascular risk factors in aging and dementia, Gene discovery in PSP by transcriptome, neuropathology and sequence analysis, ApoE pathway in cerebrovascular Aβ clearance in Alzheimer's disease, ApoE pathway in cerebrovascular Aβ clearance in Alzheimer's disease, G2743177214, G2765380810, G2822345846, G2886312875, Plasma AB as a Surrogate Genetic Marker for LOAD, G3250808129, G3556959372, G3828070099, Alzheimers Disease Patient Registry, Einstein Aging Study, Reverse apoE4 effects by apoE2 expression in Alzheimer's disease, G4162317493, Impact of ApoE2 on aging-related conditions, Metabolic Signatures Underlying Vascular Risk Factors for Alzheimer-type Dementias, Analysis of the effect of HPGDS pathway on synaptic pruning and its involvement in autism by iPS cells and 3D co-culture, Risk Factors, Pathology, and Clinical Expressions of AD, Rush Alzheimer's Disease Core Center, G5202710397, Metabolomic Signatures for Disease Sub-classification and Target Prioritization in AMP-AD, A 14 week study of mindfulness effects on attentional control in older adults, G6030318873, Microglial apoE in neuroinflammation and Alzheimer's disease, Effects of apoE isoforms on brain insulin signaling and energy metabolism in Alzheimer's disease, Florida Alzheimer's Disease Research, G6655833625, PKD1 signaling in the initiation of pancreatic cancer, Genome wide association study of gene expression levels in Alzheimer's disease, G7021464887, Arizona Alzheimer's Disease Core Center, ApoE isoform-specific therapy for Alzheimer disease, Tau and Neurodegeneration II: A therapeutic target, A Systems Approach to Targeting Innate Immunity in AD, Harnessing Molecular Networks of Resilience for Therapeutic Discoveries in AD, G7681795488, National Brain and Tissue Resource for Parkinson's Disease and Related Disorders, Metabolic Networks and Pathways in Alzheimer's Disease, G8035588433, G8559808770, ApoE and LRP1 in brain insulin signaling and glucose metabolism (Competitive Renewal), G8802763342, Regional, Synaptic, Cellular Modulation of Abeta Metabolism, Mayo Alzheimer's Disease Research Center
OpenAlex ID: W3011658331